1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 435 A phase II trial of nivolumab plus axitinib in patients with anti-PD1 refractory advanced melanoma. (9th November 2020) Authors: Shaikh, Saba; Zang, Yan; Wang, Hong; Yang, Xi; Sander, Cindy; Rose, Amy; Davar, Diwakar; Luke, Jason; Zarour, Hassane; Kirkwood, John; Delgoffe, Greg; Najjar, Yana Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma. Issue 5 (October 2017) Authors: Tarhini, Ahmad A.; Floros, Theofanis; Lin, Hui-Min; Lin, Yan; Rahman, Zahra; Ashraf, Madeeha; Vallabhaneni, Priyanka; Sander, Cindy; Rao, Uma N.M.; Panelli, Monica; LaFramboise, William F.; Kirkwood, John M. Journal: Melanoma research Issue: Volume 27:Issue 5(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma. Issue 1 (15th September 2015) Authors: Tarhini, Ahmad A.; Zahoor, Haris; Lin, Yan; Malhotra, Usha; Sander, Cindy; Butterfield, Lisa H.; Kirkwood, John M. Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Expression profiles of immune-related genes are associated with neoadjuvant ipilimumab clinical benefit. (1st February 2017) Authors: Tarhini, Ahmad A.; Lin, Yan; Lin, Hui-Min; Vallabhaneni, Priyanka; Sander, Cindy; LaFramboise, William; Hamieh, Lana Journal: Oncoimmunology Issue: Volume 6:Number 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute. Issue 1 (19th September 2017) Authors: Davar, Diwakar; Ding, Fei; Saul, Melissa; Sander, Cindy; Tarhini, Ahmad A.; Kirkwood, John M.; Tawbi, Hussein A. Journal: Journal for immunotherapy of cancer Issue: Volume 5:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Multiple primary melanoma in association with other personal and familial cancers. (5th August 2022) Authors: Yang, Xi; Karapetyan, Lilit; Huang, Ziyu; Knight, Andrew D.; Rajendran, Sneha; Sander, Cindy; Minnier, Christopher P.; Wilson, Melissa J.; Kirkwood, John M. Journal: Cancer medicine Issue: Volume 12:Number 3(2023) Page Start: 2474 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Neratinib and entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, Gαq and Gα11 and kill uveal melanoma cells. Issue 5 (4th May 2019) Authors: Booth, Laurence; Roberts, Jane L.; Sander, Cindy; Lalani, Alshad S.; Kirkwood, John M.; Hancock, John F.; Poklepovic, Andrew; Dent, Paul Journal: Cancer biology & therapy Issue: Volume 20:Issue 5(2019) Page Start: 700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗